Complete the HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population.
Ended Awarded Last action
- Contract number
- 75N91019F00137
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,222,564
Award facts
- Opportunity
-
- N02CO7240681 Solicitation number
- Contract value 100% obligated
- $9,222,564.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$13,366 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | $225,647 | |
| Supplemental Agreement for work within scope | $1,460,283 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $7,550,000 |
About this award
Leidos Biomedical Research Inc., a Federally Funded Research and Development Center contractor, received a $9.2 million delivery order from the National Institute of Allergy and Infectious Diseases (NIAID) under a cost-plus-fixed-fee contract type to complete HIV studies intended to describe the characteristics, course, and treatment response of HIV disease in the study population. The award, issued on September 30, 2019, with an ultimate completion date of March 31, 2026, is being performed at the Frederick National Laboratory for Cancer Research in Frederick, Maryland. This contract carries no set-aside designation, reflecting the contractor's established competitive capabilities in biomedical research and clinical trial support. The funding agency has noted implementation of the President's Department of Government Efficiency cost efficiency initiative as of March 19, 2025.
Leidos Biomedical Research Inc. engaged two major subcontractors to support contract execution: FHI Clinical Inc., which provides clinical research infrastructure and operations support for infectious disease studies, and Government Scientific Source Inc., a small business supplier of laboratory equipment and consumables including specialized diagnostic materials and scientific instruments. FHI Clinical Inc. brings significant expertise in clinical trials and research support services through its $545 million indefinite delivery contract with NIAID, while Government Scientific Source Inc. supplies critical laboratory materials and equipment through its General Services Administration Multiple Award Schedule vehicle. This contract demonstrates NIAID's ongoing commitment to advancing understanding of HIV disease through comprehensive clinical research initiatives conducted at federal research facilities with experienced contractors capable of managing complex, multi-year biomedical research programs.
Quick answers
Who was awarded contract 75N91019F00137?
75N91019F00137 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2019.
How much is contract 75N91019F00137 worth?
The government has obligated $9,222,564 on 75N91019F00137.
Which agency awarded contract 75N91019F00137?
National Cancer Institute (National Institutes of Health) awarded 75N91019F00137, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91019F00137 an order under another contract?
Yes. 75N91019F00137 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91019F00137 competed?
The extent of competition for 75N91019F00137 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award